Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Essence (BIOE) EBT (2020 - 2025)

Bio Essence (BIOE) has 6 years of EBT data on record, last reported at $12998.0 in Q3 2025.

  • For Q3 2025, EBT rose 101.08% year-over-year to $12998.0; the TTM value through Sep 2025 reached -$159653.0, up 89.57%, while the annual FY2024 figure was -$1.6 million, 288.31% down from the prior year.
  • EBT reached $12998.0 in Q3 2025 per BIOE's latest filing, down from $60664.0 in the prior quarter.
  • Across five years, EBT topped out at $67964.0 in Q4 2022 and bottomed at -$1.2 million in Q3 2024.
  • Average EBT over 5 years is -$172087.4, with a median of -$160993.0 recorded in 2022.
  • Peak YoY movement for EBT: surged 174.99% in 2022, then plummeted 1041.83% in 2024.
  • A 5-year view of EBT shows it stood at -$90634.0 in 2021, then surged by 174.99% to $67964.0 in 2022, then plummeted by 90.55% to $6425.0 in 2023, then plummeted by 529.0% to -$27563.0 in 2024, then surged by 147.16% to $12998.0 in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were $12998.0 in Q3 2025, $60664.0 in Q2 2025, and -$205752.0 in Q1 2025.